Breakthroughs in immune checkpoint therapy: overcoming NSCLC immune checkpoint therapy resistance with novel techniques

Immune checkpoint therapy has emerged as a revolutionary approach in the field of non-small cell lung cancer (NSCLC), offering new hope to patients with various malignancies. Despite its success, a significant proportion of patients exhibit primary or acquired resistance, limiting the efficacy of th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Li-Ping Kang, Hua-Jing Huang, Cong Xu, Hui-Hui Chen, Dong-Hui Huang, Ze-Bo Jiang
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-09-01
Col·lecció:	Frontiers in Immunology
Matèries:	immune checkpoint inhibitors NSCLC resistance mechanisms combination immunotherapy epigenetic modifiers personalized neoantigen vaccines
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1630940/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!